These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Mechanisms of activation of human mast cells and basophils by general anesthetic drugs. Marone G, Stellato C, Mastronardi P, Mazzarella B. Ann Fr Anesth Reanim; 1993; 12(2):116-25. PubMed ID: 7690200 [Abstract] [Full Text] [Related]
4. Protein Fv produced during vital hepatitis is a novel activator of human basophils and mast cells. Patella V, Bouvet JP, Marone G. J Immunol; 1993 Nov 15; 151(10):5685-98. PubMed ID: 7693815 [Abstract] [Full Text] [Related]
5. Human heart mast cells. Isolation, purification, ultrastructure, and immunologic characterization. Patella V, Marinò I, Lampärter B, Arbustini E, Adt M, Marone G. J Immunol; 1995 Mar 15; 154(6):2855-65. PubMed ID: 7533185 [Abstract] [Full Text] [Related]
6. Nimesulide, a sulfonanilide nonsteroidal anti-inflammatory drug, inhibits mediator release from human basophils and mast cells. Casolaro V, Meliota S, Marino O, Patella V, de Paulis A, Guidi G, Marone G. J Pharmacol Exp Ther; 1993 Dec 15; 267(3):1375-85. PubMed ID: 7505332 [Abstract] [Full Text] [Related]
8. Heterogeneous effects of protamine on human mast cells and basophils. Patella V, Ciccarelli A, Lamparter-Schummert B, de Paulis A, Adt M, Marone G. Br J Anaesth; 1997 Jun 15; 78(6):724-30. PubMed ID: 9215027 [Abstract] [Full Text] [Related]
9. Human heart mast cells: a definitive case of mast cell heterogeneity. Patella V, de Crescenzo G, Ciccarelli A, Marinò I, Adt M, Marone G. Int Arch Allergy Immunol; 1995 Apr 15; 106(4):386-93. PubMed ID: 7536502 [Abstract] [Full Text] [Related]
15. Effect of continuous allergen challenge on clinical symptoms and mediator release in dust-mite-allergic patients. Horak F, Toth J, Hirschwehr R, Marks B, Stübner UP, Jäger S, Berger U, Schleinzer K, Günczler P. Allergy; 1998 Jan 15; 53(1):68-72. PubMed ID: 9491231 [Abstract] [Full Text] [Related]
16. Dermal mast cell activation by autoantibodies against the high affinity IgE receptor in chronic urticaria. Niimi N, Francis DM, Kermani F, O'Donnell BF, Hide M, Kobza-Black A, Winkelmann RK, Greaves MW, Barr RM. J Invest Dermatol; 1996 May 15; 106(5):1001-6. PubMed ID: 8618029 [Abstract] [Full Text] [Related]
17. Contrast media are incomplete secretagogues acting on human basophils and mast cells isolated from heart and lung, but not skin tissue. Genovese A, Stellato C, Patella V, Lamparter-Schummert B, de Crescenzo G, Adt M, Marone G. Int J Clin Lab Res; 1996 May 15; 26(3):192-8. PubMed ID: 8905451 [Abstract] [Full Text] [Related]
18. The human recombinant c-kit receptor ligand, rhSCF, induces mediator release from human cutaneous mast cells and enhances IgE-dependent mediator release from both skin mast cells and peripheral blood basophils. Columbo M, Horowitz EM, Botana LM, MacGlashan DW, Bochner BS, Gillis S, Zsebo KM, Galli SJ, Lichtenstein LM. J Immunol; 1992 Jul 15; 149(2):599-608. PubMed ID: 1378071 [Abstract] [Full Text] [Related]
19. Quantitation of tryptase, chymase, Fc epsilon RI alpha, and Fc epsilon RI gamma mRNAs in human mast cells and basophils by competitive reverse transcription-polymerase chain reaction. Xia HZ, Kepley CL, Sakai K, Chelliah J, Irani AM, Schwartz LB. J Immunol; 1995 May 15; 154(10):5472-80. PubMed ID: 7730649 [Abstract] [Full Text] [Related]
20. A comparison of mediators released or generated by IFN-gamma-treated human mast cells following aggregation of Fc gamma RI or Fc epsilon RI. Okayama Y, Hagaman DD, Metcalfe DD. J Immunol; 2001 Apr 01; 166(7):4705-12. PubMed ID: 11254731 [Abstract] [Full Text] [Related] Page: [Next] [New Search]